Eli Lilly
Pharmaceutical company
📰 Recent Mentions
View Timeline →Weight-Loss Drugs May Slow Aging: Implications for Health in Iran
The article discusses the potential of popular weight-loss drugs to not only aid in weight reduction but also to slow biological aging. Drugmakers, particularly Eli…
Weight-loss Drugs May Also Slow Biological Aging, Say Drugmakers
Drugmakers Eli Lilly and Novo Nordisk claim that their popular weight-loss drugs may also slow biological aging, as indicated by molecular aging clocks. This development…
Eli Lilly's New Drug Shows Promise for Weight Loss in Obesity and Diabetes
A phase 2b study presented at the EASD meeting revealed that Eli Lilly's investigational drug EloraTZP led to significant weight loss and improved blood sugar…
Daily Pill Offers Alternative to Insulin Injections for Diabetes Patients at Cardiovascular Risk
Recent research presented at the EASD meeting indicates that orforglipron, a daily pill for type 2 diabetes, may provide cardiovascular safety similar to insulin injections…
Research on mRNA Storage Conditions Could Enhance Vaccine Efficacy
Researchers at The University of Texas at Austin and Eli Lilly and Company are investigating how storage conditions affect mRNA lipid nanoparticles, which are crucial…
Eli Lilly's Popular Weight Loss Drug Launches in Easier Form in the UK
Eli Lilly's Monjaro, a weight loss and diabetes medication, is set to launch in the UK in a pre-filled injection pen format, making it more…